Start the conversation
The cannabis market is estimated to grow close to $150 billion by 2025. This meant strides for weed stocks last year, but signals even greater upside for marijuana stocks in 2019.
Many still see marijuana in terms of its recreational use, but they're missing an entire emerging, lucrative market centered on its wellness and healing applications.
Cannabidiol, or CBD, is a non-hallucinogenic compound derived from the marijuana plant. Because CBD lacks the hallucinogenic properties of THC, it has become widely used to support pain relief, treatment of disease symptoms, and overall wellness.
CBD is all natural and shows huge promise for the treatment of post-traumatic stress disorder, schizophrenia, and several other conditions. It has become popular among people suffering from arthritis and chronic fatigue – it has even helped arthritic dogs and cats!
We believe CBD vendors will be among the best marijuana stocks of 2019, but there's one stock poised to land on top. Before we reveal our stock pick, here's why 2019 will be the year of CBD…
THREE STATES just legalized marijuana, and these three stocks could potentially see a 1,000% boost. Click here to learn more…
What It Looks Like for Marijuana Stocks In 2019
Money Morning Director of Cannabis Investing Research Greg Miller believes this year will go down in the history books as "the year of CBD."
Research firm Brightfield Group agrees, projecting CBD as a $2 billion market in 2019 – and $22 billion by 2022.
Loosening restrictions on marijuana and hemp are largely responsible for this continued growth.
Hemp was only made legal at the federal level in December 2018. Today, farmers of hemp can access banking services, insurance for crops, and even U.S. research grants that were only recently unavailable. Because banks and insurance firms are both regulated at the federal level, they were not willing to do business with marijuana growers until now.
Last year, the website Marijuana Moment followed 915 U.S. federal and state bills concerning marijuana, medical marijuana, and hemp. At least 147 of those were signed or enacted.
So far in 2019, state legislators and U.S. congressional representatives have filed over 350 proposals related to pot.
Legalization is even becoming a global phenomenon, as the United Nations plans to de-schedule CBD, whether it comes from hemp or marijuana plants.
Many cannabis companies await further legalization, knowing demand will grow as more hemp and marijuana products are legalized.
Meanwhile, new applications for CBD continue to be found: skin moisturizers, honey, coffee, beer, nutrition bars, gummies, and energy shots.
The burgeoning product list, combined with the rising acceptance of weed and CBD, will lead to increased distribution. This is great news for marijuana stocks in 2019 – especially this one in particular, expected to partner with several global brands to put its product on the map…